Gelonghui October 27?002022.SZ announced the third quarter report of 2023, the operating income for the reporting period was 508 million yuan, down 65.44% from the same period last year; the net profit belonging to shareholders of listed companies was-41.0822 million yuan; the net profit belonging to shareholders of listed companies after deducting non-recurring profits and losses was-44.7292 million yuan; and basic earnings per share was-0.0799 yuan.
科华生物(002022.SZ)：第三季度实现营收5.08亿元 同比下降65.44%
Kehua Biotech (002022.SZ): Achieved revenue of 508 million yuan in the third quarter, a year-on-year decrease of 65.44%
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.